http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107823182-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
filingDate 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107823182-B
titleOfInvention Potassium sodium dehydroandroan drographolide succinate enteric-coated capsule with stable drug effect and preparation method thereof
abstract The invention belongs to the field of medicine processing, and particularly relates to an andrographolide enteric-coated capsule with stable drug effect and a preparation method thereof. The method specifically comprises the following steps: the potassium sodium dehydroandroan drographolide succinate is used as an active ingredient, pharmaceutically acceptable auxiliary materials are added to form a specific formula, and the enteric-coated capsules are prepared by performing isolation layer coating and enteric coating through a specific processing technology and adding proper auxiliary materials. The preparation method of refined potassium sodium dehydroandroan drographolide succinate provided by the invention greatly reduces the generation of impurities and reduces the incidence rate of side effects; the preparation process and the parameters special for producing the potassium sodium dehydroandroan drographolide succinate enteric-coated capsules can effectively protect the active ingredients of potassium sodium dehydroandroan drographolide succinate, ensure the drug effect of the finished product and improve the bioavailability of potassium sodium dehydroandroan drographolide succinate oral administration; the invention has simple production process and easy operation and industrial production.
priorityDate 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426381608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448969875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449013851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72941912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426132826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7067324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72941925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451065094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474

Total number of triples: 57.